Cancer Prevention News and Research

RSS

Errant DNA triggers immune system response against cancer

DNA that ends up where it doesn't belong in cancer cells can unleash an immune response that makes tumors more susceptible to immunotherapy, the results of two UT Southwestern studies indicate.

17 Dec 2020

Researchers identify key gene necessary for cells to consume and destroy viruses

A team led by UT Southwestern researchers has identified a key gene necessary for cells to consume and destroy viruses. The findings, reported online today in Nature, could lead to ways to manipulate this process to improve the immune system's ability to combat viral infections, such as those fueling the ongoing COVID-19 pandemic.

17 Dec 2020

Report highlights research challenges and opportunities to advance cancer care

A new report finds that despite progress in the decline of cancer mortality, there are still critical gaps including the need to develop better tools and explore research opportunities that would lead to limiting cancer as a major health concern.

16 Dec 2020

Researchers identify cases of best practices in Europe to reduce inequalities in cancer prevention

The Area of Cancer and Public Health of the Foundation for the Promotion of Health and Biomedical Research of Valencia Region has been taking part in the consortium of the European Commission Innovative Partnership for Action Against Cancer since 2018.

14 Dec 2020

Chemists identify a new method to make valuable hydrocarbons

Inspired by light-sensing bacteria that thrive near hot oceanic vents, synthetic chemists at Rice University have found a mild method to make valuable hydrocarbons known as olefins, or alkenes.

8 Dec 2020

Study: Caplacizumab not cost effective for treating thrombotic thrombocytopenic purpura

In a new study by Yale Cancer Center researchers, the drug caplacizumab is shown not to be cost-effective in treating thrombotic thrombocytopenic purpura (TTP) when added to the standard-of-care.

7 Dec 2020

Henry Ford and United Outstanding Physicians join hands to enhance cancer care

Henry Ford Cancer Institute and United Outstanding Physicians, a physician organization comprising nearly 1,000 independent private practice physicians across Southeast Michigan, have come together to enhance cancer care and make navigating the cancer journey easier for their patients.

7 Dec 2020

Intermediate embryonic stem cell type could lead to advances in regenerative medicine

A team led by UT Southwestern has derived a new "intermediate" embryonic stem cell type from multiple species that can contribute to chimeras and create precursors to sperm and eggs in a culture dish.

4 Dec 2020

Researchers find substantial regional variation in use of genomic testing for prostate cancer

Gene-expression testing provides better estimates of cancer aggressiveness and assist in treatment decision making for men with prostate cancer.

30 Nov 2020

UC Santa Cruz teams up to launch a web portal for people at risk of heritable stomach cancers

Coinciding with Stomach Cancer Awareness Month in November, the UC Santa Cruz Genomics Institute is teaming up with the patient advocacy nonprofit No Stomach For Cancer to release a web portal designed to help researchers identify individuals at risk of heritable stomach cancers.

24 Nov 2020

Novel targeted therapy blocks metabolic pathways in cancer cells with specific genetic defects

Researchers at The University of Texas MD Anderson Cancer Center have developed a novel targeted therapy, called POMHEX, which blocks critical metabolic pathways in cancer cells with specific genetic defects.

23 Nov 2020

California law banning toxic chemicals in cosmetics will transform industry

A toxic chemical ban signed into law in California will change the composition of cosmetics, shampoos, hair straighteners and other personal care products used by consumers across the country, industry officials and activists say.

23 Nov 2020

New, non-invasive method for diagnosing and preventing colorectal cancer

Researchers from the University of Alicante(UA) and Alicante General University Hospital's Institute for Health and Biomedical Research (ISABIAL) have developed a new non-invasive method for diagnosing and preventing colorectal cancer (CRC) through the analysis of volatile organic compounds in stool samples.

19 Nov 2020

Scientists conduct randomized trial to assess e-cigarette versus traditional cigarette use

Scientists and medical professionals have long debated whether pod e-cigarettes are a safer alternative to traditional cigarettes. A new study provides some insight.

19 Nov 2020

Lower dairy intake may be beneficial for people with metabolic syndrome

Results from a new trial published by a team led by researchers at Fred Hutchinson Cancer Research Center suggests lower dairy intake may be beneficial for people with metabolic syndrome.

17 Nov 2020

Study reveals a previously undetected repertoire of cancer driver genes

A new study, led by researchers from the University of California, Irvine, has deepened the understanding of epigenetic mechanisms in tumorigenesis and revealed a previously undetected repertoire of cancer driver genes.

12 Nov 2020

Researchers discover a mechanism that cells use to degrade microRNAs

UT Southwestern researchers have discovered a mechanism that cells use to degrade microRNAs (miRNAs), genetic molecules that regulate the amounts of proteins in cells.

12 Nov 2020

Study examines the effects of simple measures on the health of active older adults

The DO-HEALTH study led by Zurich-based geriatrician Professor Heike Bischoff-Ferrari has examined the effects of simple measures on the health of healthy adults aged 70 or older.

10 Nov 2020

New resource can help predict drug sensitivity and optimize therapeutic strategies

Through large-scale profiling of protein changes in response to drug treatments in cancer cell lines, researchers at The University of Texas MD Anderson Cancer Center have generated a valuable resource to aid in predicting drug sensitivity, to understand therapeutic resistance mechanisms and to identify optimal combination treatment strategies.

6 Nov 2020

Tumor suppressor gene represses 'jumping genes'

About half of all tumors have mutations of the gene p53, normally responsible for warding off cancer. Now, UT Southwestern scientists have discovered a new role for p53 in its fight against tumors: preventing retrotransposons, or "jumping genes," from hopping around the human genome.

29 Oct 2020